Eight inhibitory monoclonal antibodies define the role of individual P- 450s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism

Drug Metabolism and Disposition

Volumn 27, Issue 1, 1999, Pages 102-109

  Yang, Tian J ^a   Krausz, Kristopher W ^a   Sai, Yang ^a   Gonzalez, Frank J ^a   Gelboin, Harry V ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYIMIPRAMINE; 7 ETHOXYCOUMARIN; CYTOCHROME P450; DESIPRAMINE; DIAZEPAM; IMIPRAMINE; MONOCLONAL ANTIBODY; NORDAZEPAM; TEMAZEPAM;

ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYDROXYLATION; LIVER MICROSOME; PRIORITY JOURNAL;

EID: 0033010360     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Alvares AV, Schilling G, Garbut A and Kuntzman R (1970) Studies on the hydroxylation of 3,4-benzpyrene by hepatic microsomes: Effect of albumin on the rate of hydroxylation of 3,4-benzpyrene. Biochem Pharmacol 19:1449-1455.
2. Ball SE, Ahern D, Scatina J and Kao J (1997) Venlafaxine: In vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs. and effects on human hepatic CYP3A4, CYP2C9 and CYPIA2. Br J Clin Pharmacol 43:619-626.
3. Bayliss MK, Bell JA, Wilson K and Park GR (1994) 7-Ethoxycoumarin O-deethylase kinetics in isolated rat, dog and human hepatocyte suspensions. Xenobiotica 24:231-241.
4. Gelboin HV (1993) Cytochromc P450 and monoclonal antibodies. Pharmacol Rev 45:413-453.
5. Gelboin HV, Goldfarb I, Krausz KW, Grogan J, Korzekwa KR. Gonzalez FJ and Shou M (1996) Inhibitory and noninhibitory monoclonal antibodies to human cytochrome P450 2E1. Chem Res Toxicol 9:1023-1030.
6. Gelboin HV, Krausz KW, Goldfarb I, Buters JT, Yang SK, Gonzalez FJ, Korzekwa KR and Shou M (1995) Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4. Biochem Pharmacol 50:1841-1850.
7. Gelboin HV, Krausz KW, Shou M, Gonzalez FJ and Yang TJ (1997) Inhibitory monoclonal antibodies define the role of cytochrome P450 in human tissue: Polymorphically expressed P450 2D6) as paradigm. Pharmacogenetics 7:467-477.
8. Gonzalez FJ (1988) The molecular biology of cytochrome P450s. Pharmacol Rev 40:243-288.
9. Gonzalez FJ, Aoyama T, and Gelboin HV (1991a) Expression of mammalian cytochrome P450 using vaccinia virus. Methods Enzymol 206:85-92.
10. Gonzalez FJ, Crespi CL and V, GH (1991b) cDNA-expressed human cytochrome P450s: A new age of molecular toxicology and human risk assessment. Mutat Res 247:113-127.
11. Guengerich FP (1995) Human cytochrome P450 enzymes. In Cytochrome P450: Structure, Mechanism, and Biochemistry (Ortiz de Montellano PR ed) pp 473-535. Plenum Press, New York.
12. Krausz KW, Yang TJ, Gonzalez FJ, Shou M and Gelboin HV (1997) Inhibitory monoclonal antibodies to human cytochrome P450 2D6. Biochem Pharmacol 54:15-17.
13. Lowry OH, Rosebrough NJ, Farr AL and Randall R (1951) Protein measurement with the Folin phenol reagent. J. Biol Chem 193:265-275.
14. Madsen H, Rasmussen BB and Brosen K (1997) Imipramine demethylation in vivo: Impact of CYP1A2, CYP2C19, and CYP3A4. Clin Pharmacol Ther 61:319-324.
15. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC and Nebert DW (1996) P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1-42.
16. Nielsen KK and Brosen K (1993) High-performance liquid Chromatography of imipramine and six metabolites in human plasma and urine. J Chromatogr 612:87-94.
17. Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
18. Ono S, Hatanaka T, Miyazawa S, Tsutsui M, Aoyama T, Gonzalez FJ and Satoh T (1996) Human liver microsomal diazepam metabolism using cDNA-expressed cylochrome P450s: Role of CYP2B6, 2C19 and the 3A subfamily. Xenobiotica 26:1155-66.
19. Park SS, Fujino T, West D, Guengerich FP and Gelboin HV (1982) Monoclonal antibodies that inhibit enzyme activity of 3-methylcholanthrene-induced cytochrome P-450. Cancer Res 42:1798-808.
20. Park SS, Waxman DJ, Lapenson DP, Schenkman JB and Gelboin HV (1989) Monoclonal antibodies to rat liver cytochrome P-450 2c/RLM5 that regiospecifically inhibit steroid metabolism. Biochem Pharmacol 38:3067-74.
21. Sai Y, Yang TJ, Krausz KW, Gonzalez FJ and Gelboin HV (1998) Inhibitory monoclonal antibodies to cytochrome P450 2A6. Pharmacogenetics, in press.
22. Vermeulen NPE (1996) Role of metablism in chemical toxicity. In Cytochromes P450: metabolic and toxicological aspects (lannides C ed) pp 29-53. CRC Press. New York.
23. Wrighton SA and Stevens JC (1992) The human hepatic cytochromes P450 involved in drug metabolism. Crit Rev Toxicol 22:1-21.
24. Yamazaki H, Inoue K, Mimura M, Oda Y, Guengerich FP and Shimada T (1996) 7-Ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes. Biochem Pharmacol 51:313-9.
25. Yang TJ, Krausz KW, Shou M, Yang SK, M., BJT, Gonzalez FJ and Gelboin HV (1998a) An inhibitory monoclonal antibody to human cytochrome P450 2B6. Biochem Pharmacol 55: 1633-1640.
26. Yang TJ, Sai Y, Krausz KW, Gonzalez FJ and Gelboin HV (1998b) Specific inhibitory monoclonal antibodies to human cytochrome P450 1A2: Analysis of phenacetin O-deethylalion in human liver. Pharmacogenetics 8:375-382.
27. Yang TJ, Shou M, Karzekwa KR, Gonzalez FJ, Gelboin HV and Yang SK (1998c) Role of cDNA-expressed human cytochromes P450 in the metabolism of diazepam. Biochemical Pharmacology 55:889-896.
28. Yasumori T, Nagata K, Yang SK, Chen L, Murayama N, Yamazoe Y and Kato R (1993) Cytochrome P450 mediated metabolism of diazepam in human and rat: Involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner. Pharmacogenetics 3:291-301.